Increasing challenges of inflammatory bowel disease in a Turkish cohort (2006-2016). [electronic resource]
Producer: 20190228Description: 373-380 p. digitalISSN:- 1784-3227
- Adalimumab -- therapeutic use
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Azathioprine -- therapeutic use
- Biological Products -- therapeutic use
- Cigarette Smoking -- epidemiology
- Colitis, Ulcerative -- epidemiology
- Crohn Disease -- epidemiology
- Digestive System Surgical Procedures -- trends
- Female
- Gastrointestinal Agents -- therapeutic use
- Glucocorticoids -- therapeutic use
- Hospitalization -- trends
- Humans
- Inflammatory Bowel Diseases -- epidemiology
- Infliximab -- therapeutic use
- Male
- Mesalamine -- therapeutic use
- Methotrexate -- therapeutic use
- Middle Aged
- Retrospective Studies
- Severity of Illness Index
- Sex Distribution
- Sulfasalazine -- therapeutic use
- Turkey -- epidemiology
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.